PuSH - Publikationsserver des Helmholtz Zentrums München

Liu, J.Z.* ; Liao, M. ; Zheng, L.* ; Li, H.R.* ; Su, X.* ; Feng, Y.H.* ; Qiu, J.M.* ; Zhang, S.W.* ; Cai, J.* ; Chen, S.Y.* ; Huang, S.Q.* ; Huang, H.K.* ; Ye, Y.B.* ; Han, S.S.* ; Zhu, S.* ; Lu, D.L.* ; Lo, K.* ; Zeng, F.F.*

Associations of breastfeeding with maternal and child health outcomes: Umbrella review.

Am. J. Clin. Nutr. 122, 1061-1074 (2025)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
BACKGROUND: Breastfeeding (BF) has been reported beneficial for both mothers and their offspring, but the evidence for these associations has not been systematically evaluated. OBJECTIVE: This umbrella review aims to assess the credibility of existing evidence regarding the associations between BF and health outcomes in mothers and offspring. METHODS: For each health outcome, evidence levels were determined using reanalyzed random-effects estimates, between-study heterogeneity, 95% predictive intervals, publication bias, small-study effects, and excess significance bias. Methodological quality was assessed by A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2), and evidence credibility was graded with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). RESULTS: Overall, 192 meta-analyses from 62 articles were included. Among maternal outcomes, three meta-analyses (3/65, 4.6%) were considered to provide convincing evidence that BF reduced the risks of ovarian cancer (odds ratio [OR] range: 0.70-0.78) and hypertension (OR range: 0.89-0.93). For short-term offspring outcomes, five meta-analyses (5/114, 4.4%) were considered to provide convincing evidence that exclusive breastfeeding (EBF) or ever BF was associated with lower risks of sudden infant death syndrome (SIDS) (OR: 0.63; 95% confidence interval [CI]: 0.54, 0.73) and allergic rhinitis (OR: 0.61; 95% CI: 0.54, 0.70), alongside improved physical fitness (standing long jump, standardized mean differences [SMDs]: 0.20-0.27). Early BF initiation (<1 hour after birth) reduced neonatal mortality risk by 56% (OR: 0.44; 95% CI: 0.33, 0.61). Regarding long-term offspring outcomes, two meta-analyses (2/13, 15.4%) were considered to offer highly suggestive and suggestive evidence, respectively, suggesting the inverse associations of ever BF on overweight/obesity and type 2 diabetes mellitus (T2DM) in adulthood. After GRADE credibility assessment, only 4 of 192 meta-analyses were classified as moderate-quality evidence. CONCLUSIONS: Our findings support the benefits of BF for mothers and their offspring, underscoring the importance of promoting BF practices to improve maternal and child health outcomes. URL OF REGISTRATION: PROSPERO CRD42023447328. This trial was registered at PROSPERO as CRD42023447328. (https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023447328).
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Breastfeeding ; Child ; Maternal ; Meta-analysis ; Umbrella Review; Environmental Risk-factors; Boyd-orr Cohort; Cancer Risk; Systematic Reviews; Preterm Infant; Metaanalysis; Postpartum; Duration; Disease; Women
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0002-9165
e-ISSN 1938-3207
Quellenangaben Band: 122, Heft: 4, Seiten: 1061-1074 Artikelnummer: , Supplement: ,
Verlag American Society for Nutrition
Verlagsort Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology (EPI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-504000-001
Förderungen National Natural Science Foundation of China
Guangdong Basic and Applied Basic Research Foundation
Scopus ID 105014606035
PubMed ID 40754214
Erfassungsdatum 2025-11-05